C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research
TUCSON, Ariz., March 28, 2024 /PRNewswire/ -- Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically …